Orca Bio

Lead, Site Onboarding and Market Enablement

Menlo Park, California, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
BiotechnologyIndustries

Position Overview

  • Location Type: Not specified
  • Job Type: Regular, Full-Time Employee
  • Salary: Not specified

Orca Bio is a late-stage biotechnology company redefining the transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks. With their purified, high-precision investigational cell therapies, Orca Bio aims to not only replace patients' blood and immune systems with healthy ones but also restore their lives.

The Site Onboarding & Market Enablement Lead will be responsible for driving the execution of Orca Bio’s treatment center onboarding, activation, and ongoing site engagement to ensure operational readiness for ORCA-T administration. This role will develop and implement scalable models and processes for site onboarding, treatment center certification, and institutional support to enable a smooth launch and sustained adoption of the therapy. This position will work cross-functionally with teams across commercial, operational, and clinical functions and will manage a growing team as the program scales.

Note: Travel ~ 30%

Responsibilities

Treatment Center Onboarding, Activation & Operational Readiness

  • Oversee the implementation of Orca Bio’s treatment center onboarding strategy, including certification processes, readiness milestones, SOPs, and training materials.
  • Oversee onboarding activities in partnership with the field teams to ensure treatment centers meet operational, regulatory, and quality standards for ORCA-T administration.
  • Design and lead a centralized onboarding and activation command center to provide day-to-day oversight, coordinate cross-functional efforts, and drive accountability.
  • Collaborate across commercial, clinical, medical, regulatory, quality, supply chain, and operational requirements.
  • Lead readiness reviews and site activation meetings to ensure alignment and accountability across functions.
  • Identify and address onboarding challenges, bottlenecks, or resource gaps to mitigate launch risk.
  • Establish KPIs, dashboards, and reporting tools to track onboarding progress and institutional readiness.

Institutional Engagement & Enablement Strategy

  • Build and maintain strong relationships with treatment center leadership, operational staff, and key opinion leaders (KOLs) to support smooth onboarding and early adoption.
  • Lead institutional engagement initiatives to ensure treatment centers are equipped with the tools, resources, and knowledge needed for successful product administration.
  • Partner with the Site Profiling function to develop and maintain a treatment center segmentation and prioritization model to guide activation strategy based on capacity, market opportunity, and readiness.

Cross-Functional Collaboration

  • Serve as the lead for treatment center onboarding within cross-functional forums, including Commercial, Medical Affairs, Regulatory, Quality, and Operations.
  • Oversee the accurate definition and integration of onboarding workflows in the ordering and CRM systems.

Team Leadership & Development

  • Lead and mentor a growing team responsible for onboarding and institutional support functions.
  • Design lean, efficient team structures and workflows that maximize onboarding effectiveness and enable scalable support for post-launch growth.

Qualifications

  • A minimum of 8-10 years of experience in site onboarding, market enablement, institutional engagement, commercial operations, or related functions within biotech/pharma.
  • Oncology, hematology, or cell therapy experience strongly preferred.
  • Proven track record in designing and executing treatment center onboarding frameworks for complex therapies (e.g., CAR-T, allogeneic transplant, gene therapy).

Skills

Site Onboarding
Operational Readiness
Treatment Center Certification
SOP Development
Cross-functional Collaboration
Team Management
Process Implementation
Regulatory Standards
Quality Standards

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI